Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Oct;83(2):449–456. doi: 10.1111/j.1476-5381.1984.tb16506.x

Biological evaluation of substance P antagonists.

K Folkers, R Håkanson, J Hörig, J C Xu, S Leander
PMCID: PMC1987101  PMID: 6207886

Abstract

Five undeca- and six C-terminal heptapeptide substance P (SP) analogues were tested for their capacity to block the contractile effect of SP on the guinea-pig isolated taenia coli. They had one feature in common, namely substitutions in positions 7 and 9 in the SP molecule. In the majority of analogues D-tryptophan was used for these substitutions. All analogues tested were found to be competitive antagonists to exogenous SP and to be capable of blocking the electrically induced non-cholinergic, non-adrenergic neuronal contraction of the taenia. Of the undecapeptides, (D-Arg1, D-Pro2, D-Trp7,9, Leu11) SP and (D-Arg1, D-Trp7,9, Leu11) SP (Spantide) had the highest pA2 value, 7.1-7.2, and the lowest IC50 value, 10(-6) M. The pA2 values of the heptapeptides were generally lower. Three of the most potent antagonists were tested for specificity and found to block the smooth muscle contraction induced by SP, physalaemin, eledoisin and bombesin but not that induced by bradykinin, carbachol, 5-hydroxytryptamine, histamine, prostaglandins and vasopressin. The SP antagonists were also tested for spasmogenic effect on the taenia and for their capacity to release histamine from rat isolated peritoneal mast cells. The spasmogenic activity displayed by most of the SP antagonists tested is likely to be related to their ability to release histamine since the contractile response was reduced by mepyramine, a histamine H1-receptor antagonist. (D-Arg1, D-Trp7,9, Leu11) SP was notable for combining a high antagonistic potency with a weak spasmogenic effect (and poor histamine releasing effect).

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burnstock G., Campbell G., Rand M. J. The inhibitory innervation of the taenia of the guinea-pig caecum. J Physiol. 1966 Feb;182(3):504–526. doi: 10.1113/jphysiol.1966.sp007834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fewtrell C. M., Foreman J. C., Jordan C. C., Oehme P., Renner H., Stewart J. M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J Physiol. 1982 Sep;330:393–411. doi: 10.1113/jphysiol.1982.sp014347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Folkers K., Hörig J., Rampold G., Lane P., Rosell S., Björkroth U. Design and synthesis of effective antagonists of substance P. Acta Chem Scand B. 1982;36(6):389–395. doi: 10.3891/acta.chem.scand.36b-0389. [DOI] [PubMed] [Google Scholar]
  5. Folkers K., Hörig J., Rosell S., Björkroth U. Chemical design of antagonists of substance P. Acta Physiol Scand. 1981 Apr;111(4):505–506. doi: 10.1111/j.1748-1716.1981.tb06771.x. [DOI] [PubMed] [Google Scholar]
  6. Folkers K., Rosell S., Xu J. C., Björkroth U., Lu Y. A., Liu Y. Z. Antagonists of substance P from emphasis on position 11. Acta Chem Scand B. 1983;37(7):623–627. doi: 10.3891/acta.chem.scand.37b-0623. [DOI] [PubMed] [Google Scholar]
  7. Håkanson R., Hörig J., Leander S. The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP. Br J Pharmacol. 1982 Dec;77(4):697–700. doi: 10.1111/j.1476-5381.1982.tb09348.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Håkanson R., Leander S., Andersson R. G., Hörig J. Substance P antagonists release histamine from peritoneal mast cells. Acta Physiol Scand. 1983 Feb;117(2):319–320. doi: 10.1111/j.1748-1716.1983.tb07215.x. [DOI] [PubMed] [Google Scholar]
  9. Kurose M., Saeki K. Histamine release induced by neurotensin from rat peritoneal mast cells. Eur J Pharmacol. 1981 Dec 3;76(2-3):129–136. doi: 10.1016/0014-2999(81)90494-5. [DOI] [PubMed] [Google Scholar]
  10. Leander S., Håkanson R., Rosell S., Folkers K., Sundler F., Tornqvist K. A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature. 1981 Dec 3;294(5840):467–469. doi: 10.1038/294467a0. [DOI] [PubMed] [Google Scholar]
  11. Lee C. M., Iversen L. L., Hanley M. R., Sandberg B. E. The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):281–287. doi: 10.1007/BF00501166. [DOI] [PubMed] [Google Scholar]
  12. Rosell S., Björkroth U., Xu J. C., Folkers K. The pharmacological profile of a substance P (SP) antagonist. Evidence for the existence of subpopulations of SP receptors. Acta Physiol Scand. 1983 Mar;117(3):445–449. doi: 10.1111/j.1748-1716.1983.tb00019.x. [DOI] [PubMed] [Google Scholar]
  13. Rönnberg A. L., Håkanson R. A simplified procedure for the fluorometric determination of histamine in rat stomach. Agents Actions. 1984 Feb;14(2):195–199. doi: 10.1007/BF01966641. [DOI] [PubMed] [Google Scholar]
  14. Sydbom A. Histamine release from isolated rat mast cells by neurotensin and other peptides. Agents Actions. 1982 Apr;12(1-2):90–93. doi: 10.1007/BF01965113. [DOI] [PubMed] [Google Scholar]
  15. Tallarida R. J., Cowan A., Adler M. W. pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 1979 Aug 20;25(8):637–654. doi: 10.1016/0024-3205(79)90505-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES